IA Insight Report
IA Insight REPORT

NAFA Pharma Portfolio

Investment Approach Details

₹0.00

(AUM CR)
   

Nafa Asset Managers Private Limited

BSE 500 TRI

Equity

Equity

24/08/2020

5.6 Years

5000000

Up to 2.5% per annum

NIL

1% for 2years since inceptions

   

The portfolio will aim at substantial capital appreciation by investing in high conviction Pharma stocks across the cap curve.

Fund Manager Details

NARAYANAN BALAJI VAIDYANATH

NA

balajivaidyanath@nafaassetmanagers.com

NA

NA

No Image

Period-Wise Performance

IA vs. Benchmark Performance

Turnover Details As On 31/01/2026

0.00

0.00